Clinical correlates of serum anti-GT1a IgG antibodies

Journal of the Neurological Sciences

Volumn 219, Issue 1-2, 2004, Pages 139-145

  Nagashima, Takahide ^a   Koga, Michiaki ^a   Odaka, Masaaki ^a   Hirata, Koichi ^a   Yuki, Nobuhiro ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti GQ1b antibody; Anti GT1a antibody; Bickerstaff's brainstem encephalitis; Fisher syndrome; Guillain Barr syndrome; Pharyngeal cervical brachial variant

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN GT1A ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; AREFLEXIA; ATAXIA; BULBAR PARALYSIS; CLINICAL FEATURE; CORRELATION ANALYSIS; DIARRHEA; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIMB; MALE; MUSCLE WEAKNESS; NECK MUSCLE; OPHTHALMOPLEGIA; PHARYNX; PRIORITY JOURNAL; REVIEW;

EID: 1642528512     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.01.005     Document Type: Article

References (23)

1. Ropper A.H., Wijdicks E.F.M., Truax B.T. Guillain-Barré syndrome. 1991;FA Davis, Philadelphia.
2. Ropper A.H. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch. Neurol. 43:1986;1150-1152.
3. Willison H.J., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 125:2002;2591-2625.
4. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. J. Neurol. Neurosurg. Psychiatry. 65:1998;218-224.
5. O'Leary C.P., Veitch J., Durward W.F., Thomas A.M., Rees J.H., Willison H.J. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a ganglioside. J. Neurol. Neurosurg. Psychiatry. 61:1996;649-651.
6. Onodera M., Mori M., Koga M.et al. Acute isolated bulbar palsy with anti-GT1a IgG antibody subsequent to Campylobacter jejuni enteritis. J. Neurol. Sci. 205:2002;83-84.
7. Mizoguchi K., Hase A., Obi T.et al. Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 57:1994;1121-1123.
8. Koga M., Yuki N., Ariga T., Morimatsu M., Hirata K. Is IgG anti-GT1a antibody associated with pharyngeal-cervical-brachial weakness or oropharyngeal palsy in Guillain-Barré syndrome? J. Neuroimmunol. 86:1998;74-79.
9. Kashihara K., Shiro Y., Koga M., Yuki N. IgG Anti-GT1a antibodies which do not cross react with GQ1b ganglioside in a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 65:1998;799.
10. Ilyas A.A., Cook S.D., Mithen F.A.et al. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome. J. Neuroimmunol. 82:1998;160-167.
11. Koga M., Yoshino H., Morimatsu M., Yuki N. Anti-GT1a IgG in Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 72:2002;767-771.
12. Okuda B., Koga M., Katsuta T., Okamoto K., Yuki N. Fulminant Guillain-Barré syndrome after Campylobacter jejuni enteritis and monospecific anti-GT1a IgG antibody. Intern. Med. 41:2002;889-891.
13. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology. 43:1993;1911-1917.
14. Yuki N., Susuki K., Hirata K. Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome. Neurology. 54:2000;1851-1853.
15. Odaka M., Yuki N., Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J. Neurol. Neurosurg. Psychiatry. 70:2001;50-55.
16. Yuki N., Tagawa Y., Irie F., Hirabayashi Y., Handa S. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α J. Neuroimmunol. 74:1997;30-34.
17. Tagawa Y., Yuki N., Hirata K. High Anti-GM1 and Anti-GD1a IgG antibody titers are detected in Guillain-Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy. Eur. Neurol. 48:2002;118-119.
18. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27:1990;S21-S24. [suppl.].
19. Shinoda T., Koh C.-S., Arakura H.et al. Immunoadsorption plasmapheresis in Guillain-Barré syndrome. Agishi T., Kawamura A., Mineshima M. Therapeutic plasmapheresis (XII). 1993;531-534 VSP, Utrecht.
20. Yuki N. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: a new approach to treatment. Neurology. 46:1996;1644-1651.
21. Yamashita H., Koga M., Morimatsu M., Yuki N. Polyneuritis cranialis related to anti-GT1a IgG antibody. J. Neurol. 248:2001;65-66.
22. Miura Y., Susuki K., Yuki N., Ayabe M., Shoji H. Guillain-Barré syndrome presenting pharyngeal-cervical-brachial weakness in the recovery phase. Eur. Neurol. 48:2002;53-54.
23. Yuki N., Hirata K. Preserved tendon reflexes in Campylobacter neuropathy. Ann. Neurol. 43:1998;546-547.